世界の自家細胞治療の市場規模は、2024年に54億1000万ドルと推定され、2025年から2030年にかけて22.01%のCAGRで成長すると予測されます。市場の成長を牽引する主な要因には、数多くの免疫学的利点、世界中の高齢者人口の割合の増加、自家細胞療法の拒絶反応のリスクの低下などがあります。自家細胞療法は、がん、神経変性疾患、心血管疾患、自己免疫疾患、整形外科、創傷治癒など、さまざまな疾患に広く使用されています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Therapeutic Area
1.2.2. Therapy Type
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Autologous Cell Therapy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of chronic and degenerative diseases
3.2.1.2. Reduced risk of autologous cell therapy rejection
3.2.1.3. Growing demand for personalized medicine
3.2.1.4. Increasing investments in research & development
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of therapy and limited affordability
3.2.2.2. Stringent regulatory requirements and long approval timelines
3.3. Autologous Cell Therapy Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. Pipeline Analysis
3.3.4. COVID-19 Impact Analysis
Chapter 4. Therapy Type Business Analysis
4.1. Global Autologous Cell Therapy Market: Therapy Type Segment Dashboard
4.2. Global Autologous Cell Therapy Market: Therapy Type Movement Analysis
4.3. Global Autologous Cell Therapy Market Estimates and Forecasts, By Therapy Type (USD Million)
4.4. Stem Cell Therapies
4.4.1. Stem cell therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. BM, Blood, & Umbilical Cord-derived Stem Cells
4.4.2.1. BM, blood, & umbilical cord-derived stem cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Adipose-Derived Cells
4.4.3.1. Adipose-Derived Cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Non-stem Cell Therapies
4.5.1. Non-stem cell therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. T-Cell Therapies
4.5.2.1. T-Cell Therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. CAR T Cell Therapy
4.5.2.2.1. CAR T cell therapy market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. T Cell Receptor (TCR)-based
4.5.2.3.1. T Cell Receptor (TCR)-based market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Others
4.5.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Therapeutic Area Business Analysis
5.1. Global Autologous Cell Therapy Market: Therapeutic Area Dashboard
5.2. Global Autologous Cell Therapy Market: Therapeutic Area Movement Analysis
5.3. Global Autologous Cell Therapy Market Estimates and Forecasts, By Therapeutic Area, Revenue (USD Million)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Cardiovascular Diseases
5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Musculoskeletal Disorders
5.6.1. Musculoskeletal disorders market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Dermatology
5.7.1. Dermatology market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework
6.3.1.3. Competitive scenario
6.3.1.4. Target disease prevalence
6.3.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework
6.3.2.3. Competitive scenario
6.3.2.4. Target disease prevalence
6.3.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework
6.4.1.3. Competitive scenario
6.4.1.4. Target disease prevalence
6.4.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework
6.4.2.3. Competitive scenario
6.4.2.4. Target disease prevalence
6.4.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Switzerland
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework
6.4.3.3. Competitive scenario
6.4.3.4. Target disease prevalence
6.4.3.5. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework
6.5.1.3. Competitive scenario
6.5.1.4. Target disease prevalence
6.5.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. Target disease prevalence
6.5.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive scenario
6.5.3.4. Target disease prevalence
6.5.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. South Korea
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive scenario
6.5.4.4. Target disease prevalence
6.5.4.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Rest of the World
6.6.1. Rest of the world market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Key Company Position Analysis, 2024
7.3. Company Profiles/Listing
7.3.1. Bluebird bio, Inc.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Novartis AG.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Holostem S.R.L
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Pharmicell Co. Inc
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Gilead Sciences, Inc. (Kite)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Bristol Myers Squibb Company
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Johnson & Johnson (Janssen Global Services, LLC.)
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. JW Therapeutics
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Vertex Pharamaceuticals Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Autolus therapeutics
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 Global Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 3 Global Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 4 Global Autologous Cell Therapy Market By Region, 2018 - 2030 (USD Million)
Table 5 North America Autologous Cell Therapy Market By Country, 2018 - 2030 (USD Million)
Table 6 North America Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 7 North America Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 8 U.S. Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 9 U.S. Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 10 Canada Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 11 Canada Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 12 Europe Autologous Cell Therapy Market By Country, 2018 - 2030 (USD Million)
Table 13 Europe Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 14 Europe Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 15 Germany Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 16 Germany Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 17 UK Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 18 UK Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 19 Switzerland Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 20 Switzerland Autologous Cell Therapy MarketBy Therapeutic Area, 2018 - 2030 (USD Million)
Table 21 Asia Pacific Autologous Cell Therapy Market By Country, 2018 - 2030 (USD Million)
Table 22 Asia Pacific Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 23 Asia Pacific Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 24 China Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 25 China Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 26 Japan Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 27 Japan Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 28 India Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 29 India Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 30 South Korea Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 31 South Korea Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 32 Rest Of The World Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 33 Rest Of The World Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Autologous Cell Therapy Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 PESTEL Analysis
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Global Autologous Cell Therapy Market: Therapy Type Key Takeaways
Fig. 12 Global Autologous Cell Therapy Market: Therapy Type Movement Analysis
Fig. 13 Global Autologous Cell Therapy Market For Autologous Stem-Cell Therapies, 2018 - 2030 (USD Million)
Fig. 14 Global Autologous Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 15 Global Autologous Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Million)
Fig. 16 Global Autologous Cell Therapy Market For Others, 2018 - 2030 (USD Million)
Fig. 17 Global Autologous Cell Therapy Market For Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 18 Global Autologous Cell Therapy Market For T-Cell Therapies, 2018 - 2030 (USD Million)
Fig. 19 Global Autologous Cell Therapy Market For CAR T Cell Therapy, 2018 - 2030 (USD Million)
Fig. 20 Global Autologous Cell Therapy Market For T Cell Receptor (TCR)-Based, 2018 - 2030 (USD Million)
Fig. 21 Global Autologous Cell Therapy Market For Other Autologous Non Stem-Cell Therapies, 2018 - 2030 (USD Million)
Fig. 22 Global Autologous Cell Therapy Market: Therapeutic Area Key Takeaways
Fig. 23 Global Autologous Cell Therapy Market: Therapeutic Area Movement Analysis
Fig. 24 Global Autologous Cell Therapy Market For Oncology, 2018 - 2030 (USD Million)
Fig. 25 Global Autologous Cell Therapy Market For Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
Fig. 26 Global Autologous Cell Therapy Market For Musculoskeletal Disorders, 2018 - 2030 (USD Million)
Fig. 27 Global Autologous Cell Therapy Market For Dermatology, 2018 - 2030 (USD Million)
Fig. 28 Global Autologous Cell Therapy Market For Others, 2018 - 2030 (USD Million)
Fig. 29 Regional Outlook, 2024 & 2030
Fig. 30 North America Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 31 U.S.Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 32 Canada Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 33 Europe Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 34 Germany Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 35 UK Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 36 Switzerland Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 38 Japan Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 39 China Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 40 India Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 41 South Korea Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 42 Rest Of The World Autologous Cell Therapy Market, 2018 - 2030 (USD Million)